Badger Capital Corp
YVR.P
Three Valley Copper Corp
TVC.H
ChitogenX Inc
CHGX
O2Gold Inc
OTGO.H
Silver Spruce Resources Inc
SSE
CA Stock MarketDetailed Quotes
LSL LSL Pharma Group Inc
- 0.380
- +0.040+11.76%
15min DelayMarket Closed Dec 16 16:00 ET
43.90MMarket Cap-12.67P/E (TTM)
0.395High0.345Low24.50KVolume0.345Open0.340Pre Close8.67KTurnover0.55052wk High0.03%Turnover Ratio115.53MShares0.34052wk Low-0.03EPS TTM30.33MFloat Cap1.000Historical HighLossP/E (Static)79.82MShs Float0.340Historical Low-0.11EPS LYR14.71%Amplitude--Dividend TTM2.16P/B1Lot Size--Div YieldTTM
LSL Pharma Group Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 59.66%4.01M | 106.05%4.19M | 105.68%4.16M | 22.08%10.03M | 51.07%3.46M | -4.94%2.51M | 43.49%2.03M | 8.51%2.02M | -6.35%8.21M | -7.65%2.29M |
| Operating revenue | 59.66%4.01M | 106.05%4.19M | 105.68%4.16M | 22.08%10.03M | 51.07%3.46M | -4.94%2.51M | 43.49%2.03M | 8.51%2.02M | -6.35%8.21M | -7.65%2.29M |
| Cost of revenue | 37.65%2.82M | 97.84%2.66M | 84.30%3.02M | -19.29%8.38M | -4.76%3.36M | -22.96%2.05M | -23.27%1.34M | -35.48%1.64M | 66.29%10.39M | 101.15%3.53M |
| Gross profit | 156.22%1.19M | 121.97%1.54M | 196.12%1.15M | 175.74%1.65M | 108.08%100K | 3,685.99%466K | 308.73%692K | 157.60%387K | -186.00%-2.17M | -270.40%-1.24M |
| Operating expense | 54.32%1.11M | 23.86%1.66M | -65.29%967K | 22.12%5.6M | -14.52%754K | -35.48%718K | 1.89%1.34M | 120.18%2.79M | 76.98%4.59M | -21.79%882.04K |
| Selling and administrative expenses | 73.91%1.07M | 34.52%1.63M | -65.67%933K | 40.85%5.39M | 16.81%581K | -41.43%617K | 0.41%1.21M | 159.46%2.72M | 47.79%3.83M | -55.90%497.39K |
| -Selling and marketing expense | ---- | -68.75%20K | 92.86%27K | -9.02%121K | ---- | ---- | -14.94%64K | -83.74%14K | -39.01%133K | -190.79%-72.92K |
| -General and administrative expense | 73.91%1.07M | 40.30%1.61M | -66.49%906K | 42.64%5.27M | -19.34%460K | -38.84%617K | 1.43%1.14M | 181.24%2.7M | 55.77%3.7M | -45.55%570.3K |
| Research and development costs | ---- | -96.97%3K | --0 | -89.54%70K | ---- | ---- | -12.39%99K | -84.39%34K | --669K | --297.65K |
| Depreciation amortization depletion | -65.35%35K | -2.94%33K | 0.00%34K | 56.32%136K | --103K | --101K | --34K | --34K | --87K | ---- |
| -Depreciation and amortization | -65.35%35K | -2.94%33K | 0.00%34K | 56.32%136K | --103K | --101K | --34K | --34K | --87K | ---- |
| Operating profit | 134.13%86K | 80.74%-125K | 107.46%179K | 41.48%-3.95M | 69.14%-654K | 77.62%-252K | 60.61%-649K | -23.84%-2.4M | -10,252.86%-6.76M | -427.59%-2.12M |
| Net non-operating interest income (expenses) | -12.21%-478K | -6.70%-414K | -15.04%-459K | -26.70%-1.76M | -69.03%-543K | -24.88%-426K | -30.44%-388K | -6.18%-399K | 18.73%-1.39M | 27.10%-321.25K |
| Non-operating interest expense | -3.61%401K | 4.37%382K | 21.86%446K | 23.82%1.57M | -23.56%422K | 121.09%416K | 23.04%366K | -2.60%366K | -20.10%1.27M | 2.47%552.08K |
| Total other finance cost | 670.00%77K | 45.45%32K | -60.61%13K | 57.63%186K | 152.42%121K | -93.46%10K | --22K | --33K | -0.42%118K | -135.45%-230.82K |
| Other net income (expenses) | 107.14%6K | 23K | -3,509.88%-2.76M | 87.33%-73K | -84K | -2.61M | -42.68%81K | -57,594,400.00%-575.94K | ||
| Gain on sale of security | ---- | ---- | ---- | 66.89%-50K | --5K | ---- | ---- | ---55K | ---151K | ---- |
| Special income (charges) | 107.14%6K | --23K | --0 | -1,268.97%-2.71M | 81.64%-78K | ---84K | --0 | ---2.55M | 64.16%232K | -42,494,400.00%-424.94K |
| -Less:Restructuring and mergern&acquisition | -107.14%-6K | ---23K | --0 | 538.12%2.71M | -81.65%78K | --84K | --0 | --2.55M | --425K | --425K |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -364.90%-657K | -5,600.00%-57 |
| Income before tax | 49.34%-386K | 50.24%-516K | 94.82%-280K | -5.09%-8.47M | 57.90%-1.27M | 48.06%-762K | 22.53%-1.04M | -133.60%-5.4M | -394.76%-8.06M | -258.08%-3.02M |
| Income tax | 0 | 0 | 0 | 0 | ||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 49.34%-386K | 50.24%-516K | 94.82%-280K | -5.09%-8.47M | 57.90%-1.27M | 48.06%-762K | 22.53%-1.04M | -133.60%-5.4M | -353.71%-8.06M | -151.70%-3.02M |
| Net income continuous operations | 49.34%-386K | 50.24%-516K | 94.82%-280K | -5.09%-8.47M | 57.90%-1.27M | 48.06%-762K | 22.53%-1.04M | -133.60%-5.4M | -353.71%-8.06M | -151.70%-3.02M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 49.34%-386K | 50.24%-516K | 94.82%-280K | -5.09%-8.47M | 57.90%-1.27M | 48.06%-762K | 22.53%-1.04M | -133.60%-5.4M | -353.71%-8.06M | -151.70%-3.02M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 49.34%-386K | 50.24%-516K | 94.82%-280K | -5.09%-8.47M | 57.90%-1.27M | 48.06%-762K | 22.53%-1.04M | -133.60%-5.4M | -353.71%-8.06M | -151.70%-3.02M |
| Diluted earnings per share | 66.46%-0.0034 | 51.22%-0.0049 | 95.86%-0.0033 | -12.19%-0.11 | 45.48%-0.02 | 10.45%-0.01 | 1.85%-0.01 | -354.39%-0.08 | -624.87%-0.098 | -302.16%-0.0367 |
| Basic earnings per share | 66.46%-0.0034 | 61.22%-0.0049 | 95.86%-0.0033 | -12.19%-0.11 | 45.48%-0.02 | 10.45%-0.01 | -23.47%-0.0126 | -354.39%-0.08 | -624.87%-0.098 | -302.16%-0.0367 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.